secwatch.observer — SEC 8-K summary
======================================

Issuer:     MapLight Therapeutics, Inc. (MPLT)
CIK:        0001770069
Form:       8-K
Filed at:   2026-06-18T21:00:35+00:00
Accession:  0001193125-26-276065
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MapLight Therapeutics fires CFO Vishwas Setia for HR violation; interim CFO named
--------------------------------------------------------------------------------

- Vishwas Setia separated as CFO effective June 18, 2026, due to human resources violation; no severance paid.
- Separation is unrelated to financial/operational results, internal controls, or clinical programs.
- Jonathan Gillis, Chief Administrative and Accounting Officer, appointed interim CFO and principal financial officer.
- Gillis continues as principal accounting officer; background in April 2026 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/0001193125-26-276065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526276065/d227825d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-276065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer